Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Plecanatide for Sale > Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide
Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide buy - large image1
Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide buy - image1
Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide buy - image2
Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide buy - image3

Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide

GMP FDA COA

Unit Price: Get Latest Price
CAS No.:

467426-54-6

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Brand:

Chengdu Shengnuo, Shengnuo Biopharm

Packaging:

g

Price valid (until):

2025-11-16

Company Type:
Manufactory
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
365 days
Qualification:
Main Products:

Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

  • Product Description

  • Seller Information

  • History Price

  • Description


      Product Detail  


    Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide

     

    CAS No.: 467426-54-6

    Purity: ≥99% (HPLC)

    Appearance: White to off-white lyophilized

    Molecular Formula: C65H104N18O26S4

    Molecular Weight: 1681.89

    Density: 1.47 ± 0.1 g/cm³ (Predicted)

    Storage   Conditions: -20°C±5°C (dry, protected from light)


    Indications

    1. Chronic idiopathic constipation (CIC)
    2. Irritable bowel syndrome with constipation (IBS-C)

     


    ECHEMI Editorial Reference
    Plecanatide is an oral guanylate cyclase-C agonist that is being developed by Synergy Pharmaceuticals for the treatment of gastrointestinal disorders, such as chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). It is a synthetic analogue of human uroguanylin, a 16 amino acid peptide that regulates ion and fluid transport in the gastrointestinal tract. In January 2017, plecanatide received its first global approval in the USA for the treatment of adult patients with CIC. Plecanatide is undergoing phase III investigation in IBS-C.
    Research & Reference Note

    Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates

    Basic Info
    Product Name:

    Plecanatide

    Other Name:

    Plecanatide;ASN-ASP-GLU-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU(DISULFIDE BOND CYS1&CYS3,CYS2&CYS4);Plecanatide Impurtiy;L-Leucine, L-asparaginyl-L-α-aspartyl-L-α-glutamyl-L-cysteinyl-L-α-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4→12),(7→15)-bis(disulfide);Plecanatide impurity;Plecanatide USP/EP/BP;Prikanatide;ATCH(1-39)

    CAS No.:

    467426-54-6

    Molecular Formula:

    C65H104N18O26S4

    InChIKeys:

    NSPHQWLKCGGCQR-DLJDZFDSSA-N

    Molecular Weight:

    1681.89

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Characteristics
    Density:

    1.47±0.1 g/cm3(Predicted)

    Boiling Point:

    2120.0±65.0 °C(Predicted)

    PKA:

    3.61±0.21(Predicted)

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1

    Location:

    Chengdu Shengnuo Biopharm Co., Ltd.

    Payment Terms:

    TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    365 days

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    Above 1000

    Year of Establishment:

    2004

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.